2025. Development And In-Vivo Evaluation Of Atorvastatin Solid Lipid Nanoparticles For Anti-Hyperlipidemic Activity. Journal of Carcinogenesis. 24, 8s (Oct. 2025), 343–351. DOI:https://doi.org/10.64149/J.Carcinog.24.8s.343-351.